Restoration of natural killer cell activity in chronic hepatitis C-infected Egyptian patients treated by sofosbuvir/daclatasvir with or without ribavirin

Restoration of natural killer cell activity in chronic hepatitis C-infected Egyptian patients treated by sofosbuvir/daclatasvir with or without ribavirin

Background and aim Numerous studies demonstrate natural killer (NK) cell dysfunction in hepatitis C virus (HCV) infection. Direct-acting antivirals (DAAs) can change NK cell activation when HCV replication is inhibited. Only few studies have reported the effect of DAAs on NK cells, especially in gen...

Full description

Bibliographic Details
Main Authors: Hamdy M Moustafa, Muhammad Abdel-Gawad, Eman M Salaheldin, Nagat F.S Ibrahim
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Al-Azhar Assiut Medical Journal
Subjects:
direct-acting antivirals therapy
hepatitis c virus
natural killer cells
Online Access:http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2021;volume=19;issue=1;spage=100;epage=106;aulast=Moustafa

Internet

http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2021;volume=19;issue=1;spage=100;epage=106;aulast=Moustafa

Similar Items